Cycloviracin B1

Cycloviracin B1 has anti-herpes simplex virus Type I (HSV-1) activity and has weak anti-Gram-positive bacterial activity[1].

Product Specifications

CAS Number

[142382-45-4]

UNSPSC

12352005

Target

Bacterial; HSV

Related Pathways

Anti-infection

Field of Research

Infection

Smiles

CO[C@H]([C@H]([C@@H]([C@H](O1)CO)O)O)[C@@H]1O[C@H](C)CCCCC[C@H](CCCCCCCCCCCCCCC[C@H]2O[C@]3([H])O[C@@](COC(C[C@H](O[C@]4([H])O[C@]([C@H]([C@@H]([C@H]4O)O)O)([H])COC(C2)=O)CCCCCCCCCCCCC[C@@H](CCCCC[C@H](O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)OC)=O)([H])[C@H]([C@@H]([C@H]3O)O)O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)OC

Molecular Formula

C83H152O33

Molecular Weight

1678.08

References & Citations

[1]Alois Fürstner, et al. Structure assignment, total synthesis, and antiviral evaluation of cycloviracin B1. J Am Chem Soc. 2003 Oct 29;125 (43) :13132-42.